Literature DB >> 18801360

The role of Neuregulin-1beta/ErbB signaling in the heart.

Laura Pentassuglia1, Douglas B Sawyer.   

Abstract

Products of the Neuregulin-1 (Nrg-1) gene, along with the ErbB family of receptor tyrosine kinases through which Nrg-1 ligands signal, play a critical role during cardiovascular development. Through studies of genetically manipulated mice, as well as studies in cells isolated from adult hearts, it appears that Nrg-1/ErbB signaling is an essential paracrine mediator of cell-cell interactions that not only regulates tissue organization during development, but also helps to maintain cardiac function throughout an organism's life. Studies in cells isolated from the heart demonstrate that Nrg-1 can activate a number of signaling pathways, which mediate cellular adaptations to stress in the myocardium. These observations provide insight as to why ErbB2-targeted cancer treatments have deleterious effects on cardiac function in some cancer patients. Moreover emerging data suggest that Nrg-1 ligands might be useful clinically to restore cardiac function after cardiac injury. In this review we will attempt to synthesize the literature behind this rapidly growing and exciting area of research.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18801360      PMCID: PMC2667947          DOI: 10.1016/j.yexcr.2008.08.015

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  112 in total

1.  Integrin alpha2beta1 recognizes laminin-2 and induces C-erb B2 tyrosine phosphorylation in metastatic human melanoma cells.

Authors:  J Han; W Jenq; N A Kefalides
Journal:  Connect Tissue Res       Date:  1999       Impact factor: 3.417

2.  Cooperative signaling between alpha(6)beta(4) integrin and ErbB-2 receptor is required to promote phosphatidylinositol 3-kinase-dependent invasion.

Authors:  D Gambaletta; A Marchetti; L Benedetti; A M Mercurio; A Sacchi; R Falcioni
Journal:  J Biol Chem       Date:  2000-04-07       Impact factor: 5.157

3.  Mice mutant for Egfr and Shp2 have defective cardiac semilunar valvulogenesis.

Authors:  B Chen; R T Bronson; L D Klaman; T G Hampton; J F Wang; P J Green; T Magnuson; P S Douglas; J P Morgan; B G Neel
Journal:  Nat Genet       Date:  2000-03       Impact factor: 38.330

4.  Cysteine-rich domain isoforms of the neuregulin-1 gene are required for maintenance of peripheral synapses.

Authors:  D Wolpowitz; T B Mason; P Dietrich; M Mendelsohn; D A Talmage; L W Role
Journal:  Neuron       Date:  2000-01       Impact factor: 17.173

5.  Tumor necrosis factor-alpha-converting enzyme is required for cleavage of erbB4/HER4.

Authors:  C Rio; J D Buxbaum; J J Peschon; G Corfas
Journal:  J Biol Chem       Date:  2000-04-07       Impact factor: 5.157

6.  FAK integrates growth-factor and integrin signals to promote cell migration.

Authors:  D J Sieg; C R Hauck; D Ilic; C K Klingbeil; E Schaefer; C H Damsky; D D Schlaepfer
Journal:  Nat Cell Biol       Date:  2000-05       Impact factor: 28.824

7.  Adenoviral gene transfer of activated phosphatidylinositol 3'-kinase and Akt inhibits apoptosis of hypoxic cardiomyocytes in vitro.

Authors:  T Matsui; L Li; Y Fukui; T F Franke; R J Hajjar; A Rosenzweig
Journal:  Circulation       Date:  1999-12-07       Impact factor: 29.690

8.  NRG-1-induced cardiomyocyte hypertrophy. Role of PI-3-kinase, p70(S6K), and MEK-MAPK-RSK.

Authors:  R R Baliga; D R Pimental; Y Y Zhao; W W Simmons; M A Marchionni; D B Sawyer; R A Kelly
Journal:  Am J Physiol       Date:  1999-11

9.  Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart.

Authors:  Y Fujio; T Nguyen; D Wencker; R N Kitsis; K Walsh
Journal:  Circulation       Date:  2000-02-15       Impact factor: 29.690

10.  Neuregulin activation of ErbB receptors in vascular endothelium leads to angiogenesis.

Authors:  K S Russell; D F Stern; P J Polverini; J R Bender
Journal:  Am J Physiol       Date:  1999-12
View more
  55 in total

Review 1.  The role of neuregulin/ErbB2/ErbB4 signaling in the heart with special focus on effects on cardiomyocyte proliferation.

Authors:  Brian Wadugu; Bernhard Kühn
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-16       Impact factor: 4.733

Review 2.  Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.

Authors:  Beth A Rose; Thomas Force; Yibin Wang
Journal:  Physiol Rev       Date:  2010-10       Impact factor: 37.312

Review 3.  Neuregulin-1 signaling in the pathogenesis of chemotherapy-induced heart failure.

Authors:  Carrie Geisberg Lenneman
Journal:  Curr Heart Fail Rep       Date:  2014-06

4.  Trastuzumab-induced cardiac dysfunction: A 'dual-hit'.

Authors:  Matthew Zeglinski; Ana Ludke; Davinder S Jassal; Pawan K Singal
Journal:  Exp Clin Cardiol       Date:  2011

5.  Binding of trastuzumab to ErbB2 is inhibited by a high pericellular density of hyaluronan.

Authors:  Tímea Váradi; Tamás Mersich; Päivi Auvinen; Raija Tammi; Markku Tammi; Ferenc Salamon; István Besznyák; Ferenc Jakab; Zsolt Baranyai; János Szöllősi; Peter Nagy
Journal:  J Histochem Cytochem       Date:  2012-05-04       Impact factor: 2.479

6.  c-Cbl inhibition improves cardiac function and survival in response to myocardial ischemia.

Authors:  Khadija Rafiq; Mikhail A Kolpakov; Rachid Seqqat; Jianfen Guo; Xinji Guo; Zhao Qi; Daohai Yu; Bhopal Mohapatra; Neha Zutshi; Wei An; Hamid Band; Archana Sanjay; Steven R Houser; Abdelkarim Sabri
Journal:  Circulation       Date:  2014-02-28       Impact factor: 29.690

7.  Optimal Objective-Based Experimental Design for Uncertain Dynamical Gene Networks with Experimental Error.

Authors:  Daniel N Mohsenizadeh; Roozbeh Dehghannasiri; Edward R Dougherty
Journal:  IEEE/ACM Trans Comput Biol Bioinform       Date:  2016-08-25       Impact factor: 3.710

8.  Critical role of nuclear calcium/calmodulin-dependent protein kinase IIdeltaB in cardiomyocyte survival in cardiomyopathy.

Authors:  Gillian H Little; Aman Saw; Yan Bai; Joan Dow; Paul Marjoram; Boris Simkhovich; Justin Leeka; Larry Kedes; Robert A Kloner; Coralie Poizat
Journal:  J Biol Chem       Date:  2009-07-14       Impact factor: 5.157

9.  Implications of Autophagy and Oxidative Stress in Trastuzumab-Mediated Cardiac Toxicities.

Authors:  N Mohan; J Jiang; W J Wu
Journal:  Austin Pharmacol Pharm       Date:  2017-08-15

10.  MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy.

Authors:  Julie Halkein; Sebastien P Tabruyn; Melanie Ricke-Hoch; Arash Haghikia; Ngoc-Quynh-Nhu Nguyen; Michaela Scherr; Karolien Castermans; Ludovic Malvaux; Vincent Lambert; Marc Thiry; Karen Sliwa; Agnes Noel; Joseph A Martial; Denise Hilfiker-Kleiner; Ingrid Struman
Journal:  J Clin Invest       Date:  2013-04-24       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.